Today's IPO for PepGen, Inc (PEPG) opened for trading earlier today at $15.60 per share after pricing 9,000,000 shares of common stock at $12. Shares have since fell back to $12.
BofA Securities, SVB Securities, and Stifel are acting as joint book-running managers for the offering. Wedbush PacGrow is acting as lead-manager for the offering.
PepGen is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases.